Sickle Cell Disease

Showing NaN - NaN of 72

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sickle Cell Disease Trial in United States (Provider-level intervention, Patient-level intervention)

Active, not recruiting
  • Sickle Cell Disease
  • Provider-level intervention
  • Patient-level intervention
  • Little Rock, Arkansas
  • +14 more
Feb 24, 2022

Cardiovascular Complications of Sickle Cell Disease

Completed
  • Sickle Cell Disease
  • MRI, Transthoracic Echocardiography, tonometry, EKG
  • Chicago, Illinois
    University of Chicago Medical Center
Feb 8, 2022

Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)

Recruiting
  • Sickle Cell Disease
  • Allogeneic Non-Myeloablative Stem Cell Transplantation
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Feb 16, 2022

Sickle Cell Disease Trial in Lebanon, United Kingdom, United States (Voxelotor)

Recruiting
  • Sickle Cell Disease
  • Oakland, California
  • +17 more
Jan 13, 2022

Sickle Cell Disease Trial in United States (bb1111)

Active, not recruiting
  • Sickle Cell Disease
  • bb1111
  • Birmingham, Alabama
  • +10 more
Dec 9, 2021

Glucose Metabolism in Sickle Cell Disease

Active, not recruiting
  • Sickle Cell Disease
  • Diabetes Mellitus
    • Chicago, Illinois
      University of Illinois at Chicago
    Nov 22, 2021

    Sickle Cell Disease Trial in Chicago (drug, radiation, procedure)

    Recruiting
    • Sickle Cell Disease
    • Chicago, Illinois
      University of Illinois at Chicago
    Oct 21, 2021

    Sickle Cell Disease Trial in United States (SHP655, Placebo)

    Recruiting
    • Sickle Cell Disease
    • Birmingham, Alabama
    • +13 more
    Aug 16, 2021

    Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)

    Active, not recruiting
    • Sickle Cell Disease
    • Graft Versus Host Disease
    • Washington, District of Columbia
    • +6 more
    Aug 4, 2021

    Sickle Cell Pro-Inflammatory Response to Interval Training Study

    Recruiting
    • Sickle Cell Disease
    • Exercise Test (CIIT)
    • Chicago, Illinois
    • +3 more
    Aug 2, 2021

    Sickle Cell Disease, Sickle B+ Thalassemia, Sickle Beta Zero Thalassemia Trial in Chicago (HU-Go app)

    Completed
    • Sickle Cell Disease
    • +3 more
    • HU-Go app
    • Chicago, Illinois
      Ann & Robert H Lurie Children's Hospital of Chicago
    Jul 27, 2021

    Sickle Cell Disease Trial in Lebanon, United Kingdom, United States (IW-1701, Placebo)

    Completed
    • Sickle Cell Disease
    • Orange, California
    • +36 more
    Jul 18, 2021

    Sickle Cell Disease Trial in Worldwide (Ticagrelor, Placebo)

    Terminated
    • Sickle Cell Disease
    • Fort Lauderdale, Florida
    • +54 more
    Mar 15, 2021

    Sickle Cell Disease Trial in United States (Mobile DOT)

    Completed
    • Sickle Cell Disease
    • Mobile DOT
    • Washington, District of Columbia
    • +3 more
    Mar 3, 2021

    Sickle Cell Disease Trial in Worldwide (voxelotor, Placebo)

    Completed
    • Sickle Cell Disease
    • Birmingham, Alabama
    • +61 more
    Jan 5, 2021

    Sickle Cell Disease, Sickle Cell Hemoglobin C, Sickle Beta Zero Thalassemia Trial in Chicago (PROs assessment using sickle cell

    Completed
    • Sickle Cell Disease
    • +3 more
    • PROs assessment using sickle cell disease mobile app (SCD-app)
    • Chicago, Illinois
      Ann & Robert H. Lurie Children's Hospital of Chicago
    Dec 17, 2020

    Sickle Cell Disease, Sickle Cell Anemia Trial in Chicago, Milwaukee (regadenoson infusion with contrast-enhanced ultrasound,

    Active, not recruiting
    • Sickle Cell Disease
    • Sickle Cell Anemia
    • regadenoson infusion with contrast-enhanced ultrasound
    • contrast-enhanced ultrasound
    • Chicago, Illinois
    • +1 more
    Oct 20, 2020

    Multi-Center Study of Iron Overload: Survey Study (MCSIO)

    Completed
    • Sickle Cell Disease
    • +2 more
      • Oakland, California
      • +7 more
      Sep 22, 2020

      Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis Trial in Canada, United States (GMI-1070, Placebo)

      Completed
      • Sickle Cell Disease
      • +2 more
      • Birmingham, Alabama
      • +21 more
      May 7, 2020

      Sickle Cell Disease Trial in Brazil, Jamaica, United States (SelG1, Placebo)

      Completed
      • Sickle Cell Disease
      • Birmingham, Alabama
      • +55 more
      Jan 21, 2020

      A 3-year, Prospective, Non-interventional, Multicenter Registry

      Completed
      • Sickle Cell Disease
        • Little Rock, Arkansas
        • +41 more
        Dec 5, 2019

        Sickle Cell Disease Trial in United States (INCB059872)

        Terminated
        • Sickle Cell Disease
        • Miami, Florida
        • +6 more
        Oct 24, 2019

        Sickle Cell Disease Trial in Worldwide (Prasugrel, Placebo)

        Terminated
        • Sickle Cell Disease
        • Oakland, California
        • +49 more
        Sep 10, 2019